NPI: 1952359986 · LAWTON, OK 73505 · General Acute Care Hospital · NPI assigned 05/04/2006
Authorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
| Authorized Official | TRAYLOR, JOHNETTA (AO) |
| NPI Enumeration Date | 05/04/2006 |
Other providers sharing the same authorized official: TRAYLOR, JOHNETTA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,455 | $1.17M |
| 2019 | 11,648 | $1.14M |
| 2020 | 8,668 | $955K |
| 2021 | 11,594 | $1.27M |
| 2022 | 18,803 | $1.86M |
| 2023 | 19,401 | $2.15M |
| 2024 | 7,142 | $862K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 17,410 | 17,203 | $2.86M |
| D9999 | Unspecified adjunctive procedure, by report | 2,755 | 2,753 | $2.48M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 8,409 | 8,296 | $2.12M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,145 | 2,117 | $800K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,863 | 1,833 | $255K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,462 | 1,442 | $97K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 448 | 245 | $89K |
| 80053 | Comprehensive metabolic panel | 7,521 | 7,377 | $76K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 820 | 812 | $63K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 100 | 57 | $54K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8,009 | 7,852 | $53K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,091 | 1,084 | $50K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 880 | 879 | $47K |
| 96375 | Therapeutic injection; each additional sequential IV push | 886 | 845 | $44K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,195 | 2,188 | $30K |
| 96361 | Intravenous infusion, hydration; each additional hour | 898 | 882 | $29K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,877 | 1,872 | $25K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 287 | 287 | $20K |
| 71045 | Radiologic examination, chest; single view | 1,702 | 1,688 | $17K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 98 | 96 | $17K |
| 87081 | 2,911 | 2,898 | $16K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 188 | 187 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 284 | 281 | $15K |
| 81025 | 1,571 | 1,560 | $12K | |
| 81001 | 4,186 | 4,130 | $11K | |
| 36415 | Collection of venous blood by venipuncture | 1,458 | 1,309 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 71 | 70 | $9K |
| 83690 | 1,451 | 1,416 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,365 | 1,335 | $8K |
| 71046 | Radiologic examination, chest; 2 views | 463 | 462 | $8K |
| 87420 | 604 | 600 | $7K | |
| 86140 | 1,414 | 1,398 | $6K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 38 | 38 | $6K |
| 83605 | 495 | 471 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 168 | 168 | $4K |
| 83735 | 659 | 645 | $4K | |
| 97597 | 599 | 272 | $3K | |
| 82150 | 558 | 547 | $3K | |
| 84484 | 271 | 216 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | 52 | 52 | $3K |
| 87400 | 205 | 205 | $2K | |
| 87430 | 167 | 167 | $2K | |
| 87040 | 189 | 140 | $2K | |
| 81003 | 892 | 882 | $2K | |
| 82553 | 173 | 170 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 12 | 12 | $1K |
| 80074 | 27 | 26 | $1K | |
| 82550 | 207 | 201 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 160 | 159 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,417 | 1,386 | $907.05 |
| 80076 | 84 | 84 | $657.18 | |
| 86704 | 38 | 37 | $450.90 | |
| 85730 | 82 | 81 | $429.30 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 28 | 28 | $425.04 |
| 83880 | 13 | 12 | $419.04 | |
| 82565 | 84 | 84 | $414.73 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 928 | 924 | $400.88 |
| 86592 | 101 | 100 | $315.40 | |
| 82803 | 14 | 13 | $301.47 | |
| 85610 | 82 | 81 | $287.97 | |
| 85027 | 41 | 41 | $218.50 | |
| 87077 | 25 | 25 | $184.88 | |
| 86900 | 49 | 48 | $162.31 | |
| 84443 | Thyroid stimulating hormone (TSH) | 12 | 12 | $149.40 |
| 86706 | 12 | 12 | $136.78 | |
| 85379 | 13 | 13 | $99.55 | |
| 85651 | 26 | 26 | $96.02 | |
| 86850 | 13 | 13 | $86.90 | |
| 86431 | 12 | 12 | $72.16 | |
| 86901 | 24 | 24 | $52.73 | |
| 82950 | 12 | 12 | $46.53 | |
| 87205 | 12 | 12 | $45.60 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 983 | 983 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 12 | 12 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,746 | 2,739 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 154 | 150 | $0.00 |